It is here described a protein which is at least one SUMO protein, or a variant or a fragment thereof or a fusion protein comprising the same for use in the treatment of neurodegenerative and/or neurological disorders. In a further embodiment, it is here described a pharmaceutical composition comprising a protein which is at least one SUMO protein or a variant or a fragment thereof or a fusion protein comprising the same and pharmaceutically acceptable carriers.
